GMP Data Integrity

ALCOA to ALCOA Plus Plus for Data Integrity in Pharma

Guidelines, Principles and Practical Examples for Modern Quality Control Laboratories.

15 min read Singapore (HSA / PIC/S) Focus

1. Introduction: Why Data Integrity is Critical

In modern pharmaceutical manufacturing and quality control (QC) testing, Data Integrity is the bedrock upon which regulatory trust, patient safety, and drug efficacy are built. Whether operating a plant in Tuas Biomedical Park or a global CDMO in Singapore, companies must guarantee that every piece of data is authentic, unaltered, and reliable.

The Regulatory Landscape

  • HSA Singapore & PIC/S: Guideline PI 041-1 serves as the gold standard for data governance.
  • US FDA & EMA: 21 CFR Part 11 and EU Annex 11 strictly enforce electronic record compliance.

2. The Evolution of the Framework

Explore how data integrity principles have evolved from basic logbook rules to enterprise cloud governance. Click the tabs below to explore each framework.

A

Attributable

Data must be traceable to the individual who recorded it. No shared credentials.

L

Legible

Records must be readable permanently. No pencil, erasable ink, or white-out allowed.

C

Contemporaneous

Recorded at the exact moment of execution. No backdating or writing on scrap paper.

O

Original

The primary data source (e.g., electronic .dat file) or a certified True Copy.

A

Accurate

Truthful, precise, and generated using validated methods and calibrated equipment.

Data Governance Framework

Top-down policies, executive accountability, and routine management reviews focusing on data health.

Quality Risk Management (ICH Q9)

Risk-based evaluations identifying critical process parameters versus low-risk utility monitoring.

Open Quality Culture

No-blame environment. Fear of reprimand is the leading driver of intentional data falsification.

Cybersecurity

Protecting GMP repositories against ransomware, network intrusions, and identity spoofing.

3. Side-by-Side Comparison

DimensionALCOA (Original)ALCOA+ALCOA++ (Modern)
Core FocusEntry-level record attributesFull data lifecycle & archivingEnterprise governance & risk
Regulatory Driver21 CFR Part 211, Basic GMP21 CFR Part 11, PIC/S PI 041-1ISPE GAMP 5, MHRA Data Guide
Primary MediaPaper records, basic printoutsElectronic databases, LIMSCloud platforms, AI/ML models
Typical ViolationFalsifying manual signaturesDisabled audit logs, missing metadataLack of executive oversight

4. Top 5 Regulatory Red Flags

Shared Logins

Multiple users sharing 'Admin' or 'QCUser' accounts.

Disabled Audit Trails

Turning off software logs to hide manual peak integrations.

Testing into Compliance

Re-running failing samples repeatedly until a pass occurs.

Unofficial Paper Scraps

Writing raw weights on post-its before formal LIMS entry.

System Clock Manipulation

Changing local PC time to backdate QC testing execution dates.

5. Data Integrity Self-Audit Checklist

Audit Readiness Score

6. Frequently Asked Questions (FAQs)


ALCOA focuses on the core attributes required for individual data entries (Attributable, Legible, Contemporaneous, Original, Accurate). ALCOA Plus (ALCOA+) extends these requirements to cover the complete lifecycle and long-term storage of electronic and paper data packages by adding Complete, Consistent, Enduring, and Available.

The Health Sciences Authority (HSA) inspects facilities based on PIC/S Document PI 041-1. HSA inspectors routinely perform live electronic software audits—directly inspecting audit trails, user privilege matrices, LIMS database tables, and raw data directories to verify that data has not been altered, deleted, or backdated.

  • Connecting printer attachments to print raw data slips immediately upon measurement.
  • Certifying thermal printouts as "True Copies" (copying to archival paper, signing, and dating).
  • Maintaining physical logbooks with strict single-strikethrough error corrections.
  • Installing modern middleware/data-loggers to capture serial RS232 port outputs directly into a validated database.
Educational Resource published by Front Life Sciences.

Empowering Pharmaceutical, Healthcare, and Biotechnology Professionals with World-Class Regulatory Knowledge.